Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Bioorganic Chemistry|December 30, 2019
New potential drug leads against MDR-MTB: A short reviewSrikanth Gatadi, Srinivas NanduriBioorganic & Medicinal Chemistry|July 21, 2019
Natural product derived promising anti-MRSA drug leads: A reviewSrikanth Gatadi, Jitendra Gour, Srinivas NanduriEuropean Journal of Medicinal Chemistry|March 19, 2019
4(3H)-Quinazolinone derivatives: Promising antibacterial drug leadsSrikanth Gatadi, T Vasanta Lakshmi, Srinivas NanduriBioorganic Chemistry|September 14, 2019
Promising antibacterial agents against multidrug resistant Staphylococcus aureusSrikanth Gatadi, Y V Madhavi, Sidharth Chopra, et al.Current Topics in Medicinal Chemistry|July 22, 2025
Unveiling Anti-Cancer Potential through ADMET Prediction, Molecular Docking, Molecular Dynamics, and In vitro Analysis: Approach to Establish Alpha-Terpineol as a Potential Drug Candidate against GliomaSagar Rout, Katarina Bauerova, Bhabani Sankar Satapathy, et al.The Journal of Organic Chemistry|May 9, 2019
A Microwave-Assisted SmI2-Catalyzed Direct N-Alkylation of Anilines with AlcoholsJitendra Gour, Srikanth Gatadi, Satyaveni Malasala, et al.Organic & Biomolecular Chemistry|August 29, 2019
Catalyst-free facile synthesis of polycyclic indole/pyrrole substituted-1,2,3-triazolesJitendra Gour, Srikanth Gatadi, Ravikumar Akunuri, et al.European Journal of Medicinal Chemistry|May 17, 2019
Synthesis and evaluation of new quinazolin-4(3H)-one derivatives as potent antibacterial agents against multidrug resistant Staphylococcus aureus and Mycobacterium tuberculosisSrikanth Gatadi, Jitendra Gour, Manjulika Shukla, et al.Bioorganic Chemistry|October 7, 2019
Facile synthesis of 1,2,3-triazole-fused indolo- and pyrrolo[1,4]diazepines, DNA-binding and evaluation of their anticancer activityJitendra Gour, Srikanth Gatadi, Venkatesh Pooladanda, et al.Bioorganic Chemistry|August 22, 2018
Synthesis of new 3-phenylquinazolin-4(3H)-one derivatives as potent antibacterial agents effective against methicillin- and vancomycin-resistant Staphylococcus aureus (MRSA and VRSA)Srikanth Gatadi, Jitendra Gour, Grace Kaul, et al.Pageof 2